Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMC Speciality Hospitals (India)BOM:524520 -0.12%84 EBITDA Margin % is 33.77% as of Mar. 2026, which is 33% above its 10-year median of 25.30. GuruFocus rates BOM:524520 with a GF Score™ of 84/100 and a GF Value™ of ₹126.93 (Fairly Valued). The stock has 5 warning signs investors should review. Among 663 Healthcare Providers & Services companies, KMC Speciality Hospitals (India) ranks better than 90.8% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
KMC Speciality Hospitals (India) EBITDA Margin % Related Terms
KMC Speciality Hospitals (India) EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524520 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, KMC Speciality Hospitals (India)'s EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMC Speciality Hospitals (India) EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, KMC Speciality Hospitals (India)'s EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where KMC Speciality Hospitals (India)'s EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMC Speciality Hospitals (India) (BOM:524520) has a EBITDA Margin % of 33.77% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on KMC Speciality Hospitals (India) and its competitors. This is 33% above median its historical median of 25.30. Over the past decade, KMC Speciality Hospitals (India)'s EBITDA Margin % has ranged from 20.37 to 30.42. According to the industry distribution chart, KMC Speciality Hospitals (India) ranks #61 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 9.2%.
Is KMC Speciality Hospitals (India)'s EBITDA Margin % too high?
KMC Speciality Hospitals (India)'s current EBITDA Margin % of 33.77% is 33% above median its 10-year median of 25.30. Over the past 10 years, this metric has ranged from a low of 20.37 to a high of 30.42. The Healthcare Providers & Services industry median EBITDA Margin % is 10.19. KMC Speciality Hospitals (India)'s value of 33.77% is 231.4% above this industry median. Based on the distribution chart, KMC Speciality Hospitals (India) ranks #61 out of 663 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, KMC Speciality Hospitals (India) has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KMC Speciality Hospitals (India)'s EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, KMC Speciality Hospitals (India) ranks #61 out of 663 companies for EBITDA Margin %. This places KMC Speciality Hospitals (India) in the top 9% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.19. KMC Speciality Hospitals (India)'s value of 33.77% is 231.4% above this benchmark. Historically, KMC Speciality Hospitals (India)'s own EBITDA Margin % has ranged from 20.37 to 30.42 over the past decade. While the company's 10-year median is 25.30 vs. the industry median of 10.19, KMC Speciality Hospitals (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.19, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMC Speciality Hospitals (India)'s current EBITDA Margin % of 33.77% is 231.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on KMC Speciality Hospitals (India) and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMC Speciality Hospitals (India)'s current EBITDA Margin % is 33.77%, which is 33% above median its own 10-year median of 25.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMC Speciality Hospitals (India) stock overvalued right now?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) (BOM:524520) is currently considered Fairly Valued. The stock's GF Value™ is ₹126.93, compared to a current price of ₹127.60 — trading 0.5% above its estimated fair value. The current EBITDA Margin % is 33.77%, which is 33% above median its 10-year median of 25.30 and 231.4% above the Healthcare Providers & Services industry median of 10.19. KMC Speciality Hospitals (India)'s overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For KMC Speciality Hospitals (India) (BOM:524520), the current EBITDA Margin % is 33.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMC Speciality Hospitals (India) (BOM:524520) Overvalued in 2026?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) stock appears to be overvalued.
The current stock price of ₹127.60 is trading 0.5% above its estimated GF Value™ of ₹126.93.
GuruFocus considers KMC Speciality Hospitals (India) to be Fairly Valued.
Key valuation signals for BOM:524520:
EBITDA Margin %: 33.77% (33% above median its 10-year median of 25.30)
GF Value™: ₹126.93 vs. price of ₹127.60 (0.5% above fair value)
Industry Position: 231.4% above the Healthcare Providers & Services median (#61 of 663)
No single metric tells the full story. See the BOM:524520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMC Speciality Hospitals (India) Ltd is a healthcare services and pharmacy company. It is engaged in the business of rendering medical and healthcare services. The company offers varieties of departments and care centers such as cardiac science, neurology and neuroscience, orthopedics, spine surgery, gastroenterology, liver diseases, and transplantation and vascular surgery. The company's sole operating segment is Medical and Healthcare Services. The company operates solely in India.
84GF Score
Get the complete analysis for BOM:524520
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524520 has been successfully added to your 
